7 completed, 2 terminated, 1 active not recruiting, 1 recruiting. 12 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 12 | Completed 7, Terminated 2, Active not recruiting 1, Recruiting 1, Unknown 1 |
Follow Vaginitis: new trials by email Literature Review of Vaginitis trials Research Report on Vaginitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Clinician-administered Vaginal Live Biotherapeutic Product LC106 - Bacterial Vaginosis | Early Phase 1 | Completed | Caroline Mitchell | 26 | 2026-04-28 | 2026-09-29 |
| Vaginal lIve Biotherapeutic RANdomized Trial LC106, LC115, Placebo - Bacterial Vaginosis | Early Phase 1 | Completed | Massachusetts General Hospital | 24 | 2024-02-01 | 2025-03-25 |
| Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome Phexxi - Bacterial Vaginosis, Vulvovaginal Candidiasis | Early Phase 1 | Recruiting | Queen's Medical Center | 22 | 2023-12-15 | 2026-02-20 |
| Multistrain Probiotics Against Bacterial Vaginosis OMNi-BiOTiC® FLORA plus+, antibiotic - Bacterial Vaginosis (BV) | Early Phase 1 | Terminated | Institut AllergoSan Pharma GmbH | 56 | 2022-12-12 | 2025-03-21 |
| Vulvovaginal Candidiasis in Canadian Females Fluconazole 150 mg, Boric Acid Supp,Vag - Candidiasis, Vulvovaginal | Early Phase 1 | Active not recruiting | University of Manitoba | 120 | 2021-12-07 | 2026-05-06 |
| Validation of a Novel Diagnostic, Prognostic Assay for Bacterial Vaginosis 750 mg metronidazole/ 200 mg miconazole vaginal suppository, Standard of care - Bacterial Vaginosis | Early Phase 1 | Unknown | Wayne State University | 200 | 2014-09-01 | 2014-11-07 |
| LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study LUXSOL copper containing cream, Metronidazole gel - Bacterial Vaginosis (BV) | Early Phase 1 | Terminated | CDA Research Group, Inc. | 50 | 2014-06-01 | 2018-04-05 |
| Preliminary Study of a Vaginal Lubrication Ring to Treat the Symptoms of Vaginal Dryness Vaginal Lubrication Ring for Vaginal Dryness - Menopausal and Perimenopausal Disorder, Unspecified, Atrophic Vaginitis | Early Phase 1 | Completed | J3 Bioscience, Inc. | 21 | 2014-01-01 | 2015-12-15 |
| Exploratory Study to Evaluate the Effects of the Probiotics L. Rhamnosus GR-1 and L. Reuteri RC-14 Lactobacillus capsules, Placebo gelatin pill - Vaginosis, Bacterial | Early Phase 1 | Completed | Kimberly-Clark Corporation | 14 | 2012-09-01 | 2014-05-15 |
| Study of the Microbiota, Metabolome, and Environmental Toxins in Relation to Reproductive Health in Rwandan Women Lactobacillus GR-1 and Lactobacillus RC-14 oral capsules, Placebo - Vulvovaginal Candidiasis, Bacterial Vaginosis | Early Phase 1 | Completed | Western University, Canada | 30 | 2012-09-01 | 2014-05-30 |
| Tinidazole for Recurrent Bacterial Vaginosis: A Pilot Study tinidazole, Placebo - Bacterial Vaginosis | Early Phase 1 | Completed | University of Pittsburgh | 37 | 2007-10-01 | 2011-02-18 |
| Management of Vaginal Complaints: A Pilot Study Within a Practice-Based Research Network Terazol or oral fluconazole for candidal vaginitis, Metronidazole or Clindamycin for Bacterial Vaginosis, Flagyl for definitively diagnosed vaginal trichomoniasis - Vaginitis | Early Phase 1 | Completed | Agency for Healthcare Research and Quality (AHRQ) | 46 | 2007-02-01 | 2014-01-08 |
Vaginosis, Bacterial (10) · Candidiasis, Vulvovaginal (4) · Atrophic Vaginitis (1) · Dyspareunia (1) · Trichomonas Vaginitis (1)
Female Urogenital Diseases (12) · Female Urogenital Diseases and Pregnancy Complications (12) · Genital Diseases (12) · Genital Diseases, Female (12) · Urogenital Diseases (12) · Vaginal Diseases (12) · Bacterial Infections and Mycoses (11) · Infections (11) · Bacterial Infections (10) · Candidiasis (4) · Mycoses (4) · Vulvar Diseases (4) · Vulvitis (4) · Vulvovaginitis (4)
Metronidazole (4) · Fluconazole (2) · Anti-Bacterial Agents (1) · Clindamycin (1) · Lacteol (1) · Probiotics (1) · Standard of Care (1) · Sugars (1) · Tinidazole (1) · terconazole (1)
Agency for Healthcare Research and Quality (AHRQ) (1) · CDA Research Group, Inc. (1) · Caroline Mitchell (1) · Institut AllergoSan Pharma GmbH (1) · J3 Bioscience, Inc. (1) · Kimberly-Clark Corporation (1) · Massachusetts General Hospital (1) · Queen's Medical Center (1) · University of Manitoba (1) · University of Pittsburgh (1) · Wayne State University (1) · Western University, Canada (1)
United States (8) · Canada (2) · South Africa (2) · Austria (1) · Rwanda (1)
Aleeza Gerstein, PhD (1) · Bliss Kaneshiro, MD, MPH (1) · Caroline M Mitchell, MD, MPH (1) · Caroline Mitchell, MD, MPH (1) · Corrie Miller, DO (1) · Disebo Potloane, MD (1) · Doris Maria Gruber, Univ. Prof. Dr. (1) · Gregor Dr Reid, PhD (1) · Jack D Sobel, MD (1) · Margit Janat-Amsbury, MD, PhD (1) · Matthew R. Anderson, MD, MSc (1) · Olivia Manayan, MD, MPH (1) · Richard Beigi, MD, MSc. (1) · Robert A Akins, PhD (1)
PMID 25127240, PMID 29912913, PMID 41050878, PMID 41382078
R21AI111103 (1)